Pregnancy outcomes in women with thalassemia major and minor: an observational cross-sectional study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20254281Keywords:
Intrauterine fetal death, Live births, Outcome, Pregnancy, Pre-term delivery, ThalassemiaAbstract
Background: Recent advances in the management of thalassemia have significantly improved life. Expectancy and quality of life in patients with this hemoglobinopathy result in a consequent increase in their reproductive potential and desire to have children. This study aimed to assess the pregnancy outcome in thalassemia patients.
Methods: This observational cross-sectional study was conducted at the Department of Obstetrics and Gynaecology of Bangabandhu Sheikh Mujib Medical University and Dhaka Medical College, Dhaka, Bangladesh, from October 2014 to March 2015. A total of 50 admitted patients in the Obstetrics and Gynaecology wards of BSMMU in the set duration of 6 months; the pregnant patients with thalassemia were enrolled in this study purposively. Data were analyzed using Microsoft Office tools.
Results: The data analysis of 50 patients yielded the following results. The mean age of 50 mothers was 27.67 (±7.59) years. The maximum 36 (72%) patients were from the 21-30 years’ age group. Among the 50 mothers with thalassemia, 8 (16%) were diagnosed with thalassemia major, and the remaining 42 (84%) were diagnosed with thalassemia minor. Pregnancy was relatively less complicated in the mothers with thalassemia major, as they were under regular ANC and regular supervision of hematologists, so that they could avoid pregnancy-induced thalassemia-related complications. But most thalassemia minor cases were undiagnosed or less emphasized before they became pregnant. So, they faced more complications. A total of 48 (96%) mothers gave birth successfully. Every mother bore a singleton pregnancy. 7 (14%) were born with low birth weight. Among them, 2 (28.57%) were found as intra uterine devices (IUD). APGAR scores of neonates at 1 min <7 were found in case of 8 cases (16%), and at 5 min were 3(6%). 12 (24%) babies required ICU admission.
Conclusion: Pregnancy is possible, safe, and usually has a favourable outcome in patients with thalassemia, in the presence of a multidisciplinary team.
References
Palit S, Bhuiyan RH, Aklima J, Emran TB, Dash R. A study of the prevalence of thalassemia and its correlation with liver function test in different age and sex group in the Chittagong district of Bangladesh. J Basic Clin Pharm. 2012;3(4):352.
Viprakasit V, Ekwattanakit S. Clinical classification, screening and diagnosis for thalassemia. Hematol Oncol Clin North Am. 2018;32(2):193-211.
Hossain MS, Raheem E, Sultana TA, Ferdous S, Nahar N, Islam S, et al. Thalassemias in South Asia: clinical lessons learnt from Bangladesh. Orphanet J Rare Dis. 2017;12(1):93.
Kattamis A, Kwiatkowski JL, Aydinok Y. Thalassaemia. Lancet. 2022;399(10343):2310-24.
Cunningham MJ. Update on thalassemia: clinical care and complications. Hematol Oncol Clin North Am. 2010;24(1):215-27.
Skordis N, Christou S, Koliou M, Pavlides N, Angastiniotis M. Fertility in female patients with thalassemia. J Pediatr Endocrinol Metab. 1998;11:935-43.
Piel FB, Weatherall DJ. The α-thalassemias. N Engl J Med. 2014;371(20):1908-16.
Mirza HM, Arzoo N, Garg M. Maternal and fetal complications and outcome of pregnancy in patients presenting with threatened abortion. Int J Life Sci Biotechnol Pharm Res. 2024;13(1).
Steinberg MH, Benz EJ Jr, Adewoye AH, Ebert BL. Pathobiology of the human erythrocyte and its hemoglobins. Hematology. 2018;447-57.
Dumars KW, Boehm C, Eckman JR, Giardina PJ, Lane PA, Shafer FE. Practical guide to the diagnosis of thalassemia. Am J Med Genet. 1996;62(1):29-37.
Chen C, Grewal J, Betran AP, Vogel JP, Souza JP, Zhang J. Severe anemia, sickle cell disease, and thalassemia as risk factors for hypertensive disorders in pregnancy in developing countries. Pregnancy Hypertens. 2018;13:141-7.
Padonou G, Le Port A, Cottrell G, Guerra J, Choudat I, Rachas A, et al. Prematurity, intrauterine growth retardation and low birth weight: risk factors in a malaria-endemic area in southern Benin. Trans R Soc Trop Med Hyg. 2014;108(2):77-83.
Adler A, Wainstock T, Sheiner E. Prenatal exposure to maternal β-thalassemia minor and the risk for long-term hematologic morbidity in the offspring. Early Hum Dev. 2021;158:105397.
Feleke BE, Feleke TE. The effect of pregnancy on hemoglobin concentration of pregnant women: a longitudinal study. J Pregnancy. 2020;2020(1):2789536.
Sampath A. Short term clinical profile of term IUGR. Rajiv Gandhi University of Health Sciences (India). 2022.
Amooee S, Samsami A, Jahanbakhsh J, Karimi M. Pregnancy outcome in patients with minor β-thalassemia. Iran J Reprod Med. 2011;9(1):9-14.
St-Georges J, Alnoman A, Badeghiesh A, Baghlaf H. Pregnancy, delivery, and neonatal outcomes among women with beta-thalassemia major: a population-based study. Arch Gynecol Obstet. 2025;311(5):1343-9.
Liaw DC, Kotkiewicz A, Kender MA. Acute splenic infarct in β-thalassemia minor. Hemoglobin. 2009;33(3-4):262-8.
Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. J Pharmacokinet Pharmacodyn. 2020;47(4):271-85.
Keramari S, Poutoglidis A, Chatzis S, Keramaris M, Savopoulos C, Kaiafa G. Parvovirus B19-associated myocarditis: a literature review of pediatric cases. Cureus. 2022;14(1).
Origa R, Comitini F. Pregnancy in thalassemia. Mediterr J Hematol Infect Dis. 2019;11(1):e2019019.
Abdollahi Z, Elmadfa I, Djazayeri A, Sadeghian S. Functional foods. Br J Nutr. 2008;100:1054-9.
Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, et al. Pregnancy outcome in women with transfused beta-thalassemia. Ann Hematol. 2022;101(2):289-96.
MacKenzie TC, Amid A, Angastiniotis M, Butler C, Gilbert S, Gonzalez J, et al. Consensus statement for perinatal management of patients with α-thalassemia major. Blood Adv. 2021;5(24):5636-9.
Downloads
Published
How to Cite
Issue
Section
